best cannabis stocks to buy canada

legalisation of medical marijuana  are looking to profit in a new market that generated $8.5 billion on legal marijuana in the U.S. last year and which is estimated to grow to $23.4 billion in 2022, according to Arcview Market Research and BDS Analytics. Cronos Group serves the medicinal market through its PeaceNaturals brand and the recreational market through brands including Cove and Spinach. The company has struck numerous partnerships to scale up and expand. It has a deal for MediPharm Labs to supply it with product to ensure it has enough to develop new derivative products in Canada, and has gained access to exclusive technology from Ginkgo Bioworks that should help it produce pure cultured cannabinoids at scale (lowering the cost) by leveraging existing fermentation infrastructure owned by the likes of breweries and pharmaceutical companies. It has also teamed up to bolster its efforts to enter the vape market.